Literature DB >> 36157141

A Quick Score to Transfer Alcohol-Associated Hepatitis Patients for Early Liver Transplantation.

Raghuram Reddy1, Anand V Kulkarni2.   

Abstract

Entities:  

Keywords:  AAH, alcohol-associated hepatitis; ARLD, alcohol-related liver disease; LT, Liver transplantation; MELD, model for end-stage liver disease; TLFB, timeline follow-back

Year:  2022        PMID： 36157141      PMCID： PMC9499838          DOI： 10.1016/j.jceh.2022.05.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  8 in total

1.  Early liver transplantation for severe alcoholic hepatitis.

Authors:  Philippe Mathurin; Christophe Moreno; Didier Samuel; Jérôme Dumortier; Julia Salleron; François Durand; Hélène Castel; Alain Duhamel; Georges-Philippe Pageaux; Vincent Leroy; Sébastien Dharancy; Alexandre Louvet; Emmanuel Boleslawski; Valerio Lucidi; Thierry Gustot; Claire Francoz; Christian Letoublon; Denis Castaing; Jacques Belghiti; Vincent Donckier; François-René Pruvot; Jean-Charles Duclos-Vallée
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

2.  Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.

Authors:  Brian P Lee; Neil Mehta; Laura Platt; Ahmet Gurakar; John P Rice; Michael R Lucey; Gene Y Im; George Therapondos; Hyosun Han; David W Victor; Oren K Fix; Lisanne Dinges; Deepti Dronamraju; Christine Hsu; Michael D Voigt; Mary E Rinella; Haripriya Maddur; Sheila Eswaran; Jessica Hause; David Foley; R Mark Ghobrial; Jennifer L Dodge; Zhiping Li; Norah A Terrault
Journal:  Gastroenterology       Date:  2018-04-12       Impact factor: 22.682

3.  The reliability of the Alcohol Timeline Followback when administered by telephone and by computer.

Authors:  L C Sobell; J Brown; G I Leo; M B Sobell
Journal:  Drug Alcohol Depend       Date:  1996-09       Impact factor: 4.492

4.  Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study.

Authors:  Alexandre Louvet; Julien Labreuche; Christophe Moreno; Claire Vanlemmens; Romain Moirand; Cyrille Féray; Jérôme Dumortier; Georges-Philippe Pageaux; Christophe Bureau; Faïza Chermak; Christophe Duvoux; Dominique Thabut; Vincent Leroy; Nicolas Carbonell; Benjamin Rolland; Ephrem Salamé; Rodolphe Anty; Jérôme Gournay; Jean Delwaide; Christine Silvain; Valerio Lucidi; Guillaume Lassailly; Sébastien Dharancy; Eric Nguyen-Khac; Didier Samuel; Alain Duhamel; Philippe Mathurin
Journal:  Lancet Gastroenterol Hepatol       Date:  2022-02-23

5.  The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

Authors:  Alexandre Louvet; Sylvie Naveau; Marcelle Abdelnour; Marie-José Ramond; Emmanuel Diaz; Laetitia Fartoux; Sébastien Dharancy; Frédéric Texier; Antoine Hollebecque; Lawrence Serfaty; Emmanuel Boleslawski; Pierre Deltenre; Valérie Canva; François-René Pruvot; Philippe Mathurin
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

6.  Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.

Authors:  Thomas G Cotter; Burhaneddin Sandıkçı; Sonali Paul; Anuhya Gampa; Jennifer Wang; Helen Te; Anjana Pillai; Kapuluru G Reddy; Diego di Sabato; Ester C Little; Vinay Sundaram; John Fung; Michael R Lucey; Michael Charlton
Journal:  Am J Transplant       Date:  2020-08-13       Impact factor: 8.086

7.  Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score-Which Is Better?

Authors:  Anand V Kulkarni; Pramod Kumar; Mithun Sharma; Balachandran Menon; D Nageshwar Reddy; P Nagaraja Rao
Journal:  Hepatology       Date:  2021-05-17       Impact factor: 17.425

8.  Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.

Authors:  Juan Pablo Arab; Luis Antonio Díaz; Natalia Baeza; Francisco Idalsoaga; Eduardo Fuentes-López; Jorge Arnold; Carolina A Ramírez; Dalia Morales-Arraez; Meritxell Ventura-Cots; Edilmar Alvarado-Tapias; Wei Zhang; Virginia Clark; Douglas Simonetto; Joseph C Ahn; Seth Buryska; Tej I Mehta; Horia Stefanescu; Adelina Horhat; Andreea Bumbu; Winston Dunn; Bashar Attar; Rohit Agrawal; Zohaib Syed Haque; Muhammad Majeed; Joaquín Cabezas; Inés García-Carrera; Richard Parker; Berta Cuyàs; Maria Poca; German Soriano; Shiv K Sarin; Rakhi Maiwall; Prasun K Jalal; Saba Abdulsada; María Fátima Higuera-de la Tijera; Anand V Kulkarni; P Nagaraja Rao; Patricia Guerra Salazar; Lubomir Skladaný; Natália Bystrianska; Veronica Prado; Ana Clemente-Sanchez; Diego Rincón; Tehseen Haider; Kristina R Chacko; Fernando Cairo; Marcela de Sousa Coelho; Gustavo A Romero; Florencia D Pollarsky; Juan Carlos Restrepo; Susana Castro-Sanchez; Luis G Toro; Pamela Yaquich; Manuel Mendizabal; Maria Laura Garrido; Adrián Narvaez; Fernando Bessone; Julio Santiago Marcelo; Diego Piombino; Melisa Dirchwolf; Juan Pablo Arancibia; José Altamirano; Won Kim; Roberta C Araujo; Andrés Duarte-Rojo; Victor Vargas; Pierre-Emmanuel Rautou; Tazime Issoufaly; Felipe Zamarripa; Aldo Torre; Michael R Lucey; Philippe Mathurin; Alexandre Louvet; Guadalupe García-Tsao; José Alberto González; Elizabeth Verna; Robert S Brown; Juan Pablo Roblero; Juan G Abraldes; Marco Arrese; Vijay H Shah; Patrick S Kamath; Ashwani K Singal; Ramon Bataller
Journal:  J Hepatol       Date:  2021-06-21       Impact factor: 25.083
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.